Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 13 years, the highest Dividend Payout Ratio of Immuno-Biological Laboratories Co was 0.17. The lowest was 0.17. And the median was 0.17.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Immuno-Biological Laboratories Co (TSE:4570) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Immuno-Biological Laboratories Co Dividend Yield % Chart
TSE:4570 vs VRTX, REGN, ALNY: Dividend Yield % Comparison
For the Biotechnology subindustry, Immuno-Biological Laboratories Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Immuno-Biological Laboratories Co Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Immuno-Biological Laboratories Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Immuno-Biological Laboratories Co's Dividend Yield % falls into.
Immuno-Biological Laboratories Co Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Immuno-Biological Laboratories Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
JPY 6.000000
2026-03-30
2026-03-31
2026-06-26
Cash Dividend
semi-annually
JPY:JPY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Immuno-Biological Laboratories Co (TSE:4570) has a Dividend Yield % of 0.60% as of Jul. 13, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Immuno-Biological Laboratories Co and its competitors. This is 20% above median its historical median of 0.50. Over the past decade, Immuno-Biological Laboratories Co's Dividend Yield % has ranged from 0.40 to 0.65. According to the industry distribution chart, Immuno-Biological Laboratories Co ranks #117 out of 153 companies in the Biotechnology industry, placing it in the top 76.5%.
Is Immuno-Biological Laboratories Co's Dividend Yield % too high?
Immuno-Biological Laboratories Co's current Dividend Yield % of 0.60% is 20% above median its 10-year median of 0.50. Over the past 10 years, this metric has ranged from a low of 0.40 to a high of 0.65. The Biotechnology industry median Dividend Yield % is 1.38. Immuno-Biological Laboratories Co's value of 0.60% is 56.5% below this industry median. Based on the distribution chart, Immuno-Biological Laboratories Co ranks #117 out of 153 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Immuno-Biological Laboratories Co has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Immuno-Biological Laboratories Co's Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Immuno-Biological Laboratories Co ranks #117 out of 153 companies for Dividend Yield %. This places Immuno-Biological Laboratories Co in the lower half of its industry. The industry median Dividend Yield % is 1.38. Immuno-Biological Laboratories Co's value of 0.60% is 56.5% below this benchmark. Historically, Immuno-Biological Laboratories Co's own Dividend Yield % has ranged from 0.40 to 0.65 over the past decade. While the company's 10-year median is 0.50 vs. the industry median of 1.38, Immuno-Biological Laboratories Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.38, based on 153 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Immuno-Biological Laboratories Co's current Dividend Yield % of 0.60% is 56.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Immuno-Biological Laboratories Co and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Immuno-Biological Laboratories Co's current Dividend Yield % is 0.60%, which is 20% above median its own 10-year median of 0.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Immuno-Biological Laboratories Co stock overvalued right now?
Based on GuruFocus' analysis, Immuno-Biological Laboratories Co (TSE:4570) is currently considered Significantly Overvalued. The stock's GF Value™ is 円578.80, compared to a current price of 円994.00 — trading 71.7% above its estimated fair value. The current Dividend Yield % is 0.60%, which is 20% above median its 10-year median of 0.50 and 56.5% below the Biotechnology industry median of 1.38. Immuno-Biological Laboratories Co's overall GF Score™ is 58/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Immuno-Biological Laboratories Co (TSE:4570), the current Dividend Yield % is 0.60% as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Immuno-Biological Laboratories Co (TSE:4570) Overvalued in 2026?
Based on GuruFocus' analysis, Immuno-Biological Laboratories Co stock appears to be overvalued.
The current stock price of 円994.00 is trading 71.7% above its estimated GF Value™ of 円578.80.
GuruFocus considers Immuno-Biological Laboratories Co to be Significantly Overvalued.
Key valuation signals for TSE:4570:
Dividend Yield %: 0.60% (20% above median its 10-year median of 0.50)
GF Value™: 円578.80 vs. price of 円994.00 (71.7% above fair value)
Industry Position: 56.5% below the Biotechnology median (#117 of 153)
No single metric tells the full story. See the TSE:4570 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Immuno-Biological Laboratories Co Business Description
Immuno-Biological Laboratories Co Ltd focuses on research and development. It researches, develops, manufacture and supplies various immunological research reagents, and customized services. It is engaged in research and development of materials used in diagnostic products and valuable seeds and technology for protein production using transgenic silkworm cocoons, which make it possible to create valuable proteins as well as antibodies. It works on clinical reagents for cancer research. Its research scientists are producing inflammatory cytokines, growth factors & antibodies for use against these cancers.
58GF Score
Get the complete analysis for TSE:4570
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4570 has been successfully added to your 
